Sign In
Home
About Us
Benefits
Pricing
Krixos Global Intel
Krixos
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Krixos Health:
Sign Up Now:
Your email:
or call us on: +43 (0)1 27 63 015
or email:
subscribe@krixos.com
Most viewed
1.
Avidicure to Present Preclinical Data from Lead TROP2-targeting Multifunctional Antibody Program at the 2025 American Society of Clinical Oncology Annual Meeting
2.
Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
3.
Interpretable machine learning model integrating contrast-enhanced CT environmental radiomics and clinicopathological features for predicting postoperative recurrence in lung adenocarcinoma: a retrospective pilot study
4.
SystImmune, Inc. to Present New izalontamab brengitecan (iza-bren) Data in Small Cell Lung Cancer and Non-Small Cell Lung Cancer with Driver Genomic Alterations (GA) outside of Classic EGFR Mutations at ASCO Congress 2025
5.
Piers Morgan Asks Jason Miller About Possibility of Charging Jill Biden With ‘Elder Abuse'
6.
Watch: 'Dilbert' Creator Scott Adams Says Trump Called, Twice, to Wish Him Well After Cancer Diagnosis
7.
Biden's Prostate Cancer Likely Grew Undetected for Years, Experts Say
8.
Dilbert cartoonist reveals Trump personally reached out following his terminal cancer announcement
9.
Hotspots and frontiers of the relationship between gastric cancer and cancer-associated fibroblasts: a bibliometric analysis
10.
Inflammation as a key mediator: linking triglyceride-glucose index to prognosis in non-muscle-invasive bladder cancer
Last updated at 18:58 GMT
Hot News Makers
Health/Pharma Companies
PAHO
5623.00
Barts Health
4237.51
Fresenius Kabi
2884.44
Walter Reed Medical
1179.28
BioMarker Strategies
1163.38
Neuraxpharm
581.69
Vivus
393.26
Recordati Rare Diseases
357.87
Sino Biological
348.70
Acella Pharmaceuticals
302.20
Drugs, Treatments, Trials
Denosumab
9779.07
Prolia
3083.99
Eliglustat
746.32
Navitoclax
442.26
Zyban
415.43
Curcumin
326.50
Xgeva
180.12
Belantamab Mafodotin
176.24
Triclonics
145.17
Blenrep
142.73
Last updated at 18:10 GMT